Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

BACKGROUND: The aim of the present study was to investigate the efficacy of adjuvant dose-dense sequential chemotherapy with epirubicin, paclitaxel, and CMF in subgroups of patients with high-risk operable breast cancer, according to tumor subtypes defined by immunohistochemistry (IHC). MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzilas, George, Dafni, Urania, Bobos, Mattheos, Batistatou, Anna, Kotoula, Vassiliki, Trihia, Helen, Malamou-Mitsi, Vassiliki, Miliaras, Spyros, Chrisafi, Sofia, Papadopoulos, Savvas, Sotiropoulou, Maria, Filippidis, Theodoros, Gogas, Helen, Koletsa, Triantafyllia, Bafaloukos, Dimitrios, Televantou, Despina, Kalogeras, Konstantine T., Pectasides, Dimitrios, Skarlos, Dimosthenis V., Koutras, Angelos, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367950/
https://www.ncbi.nlm.nih.gov/pubmed/22679488
http://dx.doi.org/10.1371/journal.pone.0037946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367950/
https://www.ncbi.nlm.nih.gov/pubmed/22679488
http://dx.doi.org/10.1371/journal.pone.0037946

Ejemplares similares